CIK 0001788028 · <br>Emerging growth company
Jasper Therapeutics, Inc.
Sign in to watch- Ticker
- JSPR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842984849
- Phone
- 6505491400
- Business address
- 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
- Former names
- Amplitude Healthcare Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-03 | Brun Scott C. Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-07-03 | EMSTER KURT VON Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-07-03 | Shizuru Judith Anne Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-07-03 | Nolet Chris Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-07-03 | Kapoor Vishal Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-07-03 | WIGGANS THOMAS G Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-07-03 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2025-06-04 | MARTELL RON President and CEO | Grant or award · Stock Option (right to buy) | +234,000 | 234,000 | ||
| 2025-06-04 | Mahal Jeetinder Singh Chief Operating Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-06-04 | CROSS HERB Chief Financial Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-06-04 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-02-13 | Mahal Jeetinder Singh Chief Operating Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-02-13 | MARTELL RON President, CEO and Director | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2025-02-13 | CROSS HERB Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-02-13 | Tucker Edwin Jonathan Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-12-12 | Mahal Jeetinder Singh Chief Operating Officer | Option exercise 10b5-1 | +900 | $7.10 | $6K | 25,909 |
| 2024-12-12 | Mahal Jeetinder Singh Chief Operating Officer | Sale 10b5-1 | −900 | $22.11 | $20K | 25,009 |
| 2024-12-12 | Mahal Jeetinder Singh Chief Operating Officer | Option exercise · Stock Option (right to buy) 10b5-1 | +900 | 13,772 | ||
| 2024-09-12 | Mahal Jeetinder Singh Chief Operating Officer | Option exercise 10b5-1 | +900 | $7.10 | $6K | 25,909 |
| 2024-09-12 | Mahal Jeetinder Singh Chief Operating Officer | Sale 10b5-1 | −900 | $21.23 | $19K | 25,009 |
Page 2 of 7 · 129 trades